Skip to main navigation Skip to search Skip to main content

A Multicenter, Sham-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Clinical Responses following Stereotactic Intracranial Implantation of DSP-1083 into Subjects with Parkinson's Disease

Grants and Contracts Details

StatusActive
Effective start/end date10/7/24 → 10/7/26

Funding

  • IQVIA RDS Incorporated: $109,376.00